TNF-alpha trap/anti-IL-6 bispecific antibody (Kodiak Sciences)

N/A

Report date: 2025/06/11 10:58:13

Base Information

Drug NameTNF-alpha trap/anti-IL-6 bispecific antibody (Kodiak Sciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor α inhibitorsInterleukin-6 inhibitors
TargetsInterleukin-6Tumor necrosis factor α
Therapy Area/IndicationsOcular inflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKodiak Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesKodiak Sciences Inc
Inactive CompaniesN/A
Active IndicationsOcular inflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A